The importance of alkynyl chain presence for the activity of adenine nucleosides/nucleotides on purinergic receptors

Current Medicinal Chemistry

Volumn 18, Issue 10, 2011, Pages 1444-1463

  Dal Ben, D ^a   BuccioniM , ^a   Lambertucci, C ^a   Marucci, G ^a   Volpini, R ^a   Cristalli, G ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

Author keywords

Adenine; Adenosine; Agonists; Alkynyl substituent; Antagonists; Nucleosides; Nucleotides; Purinergic receptors

Indexed keywords

ADENINE DERIVATIVE; ADENINE NUCLEOTIDE; ADENOSINE DEAMINASE; ADENOSINE DIPHOSPHATE; ADENOSINE KINASE; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; ALKYNYL GROUP; IONOTROPIC RECEPTOR; METHYLXANTHINE; NUCLEOSIDE; PURINE DERIVATIVE; PURINERGIC P2 RECEPTOR; PURINERGIC RECEPTOR; URIDINE TRIPHOSPHATE;

ARTICLE; BINDING AFFINITY; DEAMINATION; DRUG POTENCY; HUMAN; LIGAND BINDING; MOLECULAR MODEL; NONHUMAN; PHOSPHORYLATION; STRUCTURE ACTIVITY RELATION;

ADENINE; ADENINE NUCLEOTIDES; ANIMALS; HUMANS; NUCLEOTIDES; PURINE NUCLEOSIDES; RECEPTORS, PURINERGIC; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79955043177     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986711795328391     Document Type: Article

References (136)

1. Burnstock, G. Purinergic nerves. Pharmacol. Rev., 1972, 24(3), 509-581.
2. Burnstock, G. Purinergic receptors. J. Theor. Biol., 1976, 62(2), 491-503.
3. Burnstock, G. In Cell Membrane Receptors for Drugs and Hormones: A MultidisciplinaryApproach. Straub, R.W.; Bolis, L., Eds.; Raven Press: New York, 1978, pp 107-118.
4. van Calker, D.; Muller, M.; Hamprecht, B. Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J. Neurochem., 1979, 33(5), 999-1005. (Pubitemid 10188731)
5. Londos, C.; Cooper, D.M.; Wolff, J. Subclasses of external adenosine receptors. Proc. Natl Acad. Sci. U. S. A., 1980, 77(5), 2551-2554. (Pubitemid 10049819)
6. Burnstock, G.; Kennedy, C. Is there a basis for distinguishing two types of P2-purmoceptor? Gen. Pharmacol, 1985, 16(5), 433-440. (Pubitemid 16250911)
7. Fredholm, B.B.; IJzerman, A.P.; Jacobson, K.A.; Klotz, K.-N.; Linden, J. International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev, 2001, 53(4), 527-552. (Pubitemid 33136237)
8. Burnstock, G. Purine and pyrimidine receptors. Cell. Mol. Life Sci., 2007, 64(12), 1471-1483. (Pubitemid 46954150)
9. Jacobson, K.A. Introduction to adenosine receptors as therapeutic targets. Handb. Exp. Pharmacol, 2009, 193, 1-24.
10. Burnstock, G. Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol. Rev, 2006, 58(1), 58-86.
11. Pfleger, K.; Seifen, E.; Schondorf, H. Potenzierung der adenosinwirkung am herzen durch inosin [Inosine potentiation of the effect of adenosine on the heart]. Biochem. Pharmacol, 1969, 18(1), 43-51.
12. Cristalli, G.; Costanzi, S.; Lambertucci, C.; Lupidi, G.; Vittori, S.; Volpini, R.; Camaioni, E. Adenosine deaminase: functional implications and different classes of inhibitors. Med. Res. Rev., 2001, 21(2), 105-128. (Pubitemid 32185243)
13. Maguire, M.H.; Nobbs, D.M.; Einstein, R.; Middleton, J.C. 2-Alkylthioadenosines, specific coronary vasodilators. J. Med. Chem., 1971, 14(5), 415-420.
14. Cristalli, G.; Volpini, R. Adenosine receptors: chemistry and pharmacology. Curr. Top. Med. Chem., 2003, 3(4), 355-469.
15. Matsuda, A.; Shinozaki, M.; Miyasaka, T.; Machida, H.; Abiru, T. Palladium-catalyzed cross-coupling of 2-iodoadenosine with terminal alkynes: synthesis and biological activities of 2-alkynyladenosines. Chem. Pharm. Bull. (Tokyo), 1985, 33(4), 1766-1769. (Pubitemid 15046109)
16. Matsuda, A.; Ueda, T. The Synthesis, Mutagenic and Pharmacological Activities of 2-Carbon-Substituted Adenosines. Nucleosides Nucleotides, 1987, 6(1), 85-94. (Pubitemid 17127325)
17. Cristalli, G.; Eleuteri, A.; Grifantini, M.; Vittori, S.; Volpini, R.; Klotz, K.-N.; Lohse, M.J. In International Symposium on Pharmacology of Purinergic Receptors-IUPHAR Satellite Symposium: Noordwijk (The Netherlands), 1990.
18. 2 receptors. Eur. J. Pharmacol., 1991, 196(1), 69-76.
19. Matsuda, A.; Shinozaki, M.; Yamaguchi, T.; Homma, H.; Nomoto, R.; Miyasaka, T.; Watanabe, Y.; Abiru, T. Nucleosides and nucleotides. 103. 2-Alkynyladenosines: a novel class of selective adenosine A2 receptor agonists with potent antihypertensive effects. J. Med. Chem., 1992, 35(2), 241-252.
20. 2 receptor agonists with potent antihypertensive effects. J. Med. Chem., 1992, 35(12), 2253-2260.
21. 2 adenosine receptor agonists with potent antihypertensive activity. J. Med. Chem., 1992, 35(15), 2881-2890.
22. Palczewski, K.; Kumasaka, T.; Hori, T.; Behnke, C.A.; Motoshima, H.; Fox, B. A.; Le Trong, I.; Teller, D.C.; Okada, T.; Stenkamp, R.E.; Yamamoto, M.; Miyano, M. Crystal structure of rhodopsin: A G protein-coupled receptor. Science, 2000, 289(5480), 739-745. (Pubitemid 30650186)
23. 2A adenosine receptor bound to an antagonist. Science, 2008, 322(5905), 1211-1217.
24. 2A crystal structure tell us? Curr. Top. Med. Chem., 2010, 10(10), 993-1018.
25. Camaioni, E.; Costanzi, S.; Vittori, S.; Volpini, R.; Klotz, K.-N.; Cristalli, G. New substituted 9-alkylpurines as adenosine receptor ligands. Bioorg. Med. Chem., 1998, 6(5), 523-533. (Pubitemid 28264075)
26. Volpini, R.; Costanzi, S.; Lambertucci, C.; Vittori, S.; Martini, C.; Trincavelli, M.L.; Klotz, K.-N.; Cristalli, G. 2-and 8-alkynyl-9-ethyladenines: Synthesis and biological activity at human and rat adenosine receptors. Purinergic Signal., 2005, 1(2), 173-181. (Pubitemid 40466902)
27. 2B receptor. J. Med. Chem., 2001, 44(2), 170-179. (Pubitemid 32096661)
28. 2B adenosine receptor. Bioorg. Med. Chem., 2001, 9(10), 2709-2726. (Pubitemid 32824173)
29. 3 adenosine antagonists: structural homology and receptor docking. J. Chem. Inf. Comput. Sci., 1998, 38(6), 1239-1248. (Pubitemid 128591291)
30. Borrmann, T.; Abdelrahman, A.; Volpini, R.; Lambertucci, C.; Alksnis, E.; Gorzalka, S.; Knospe, M.; Schiedel, A.C.; Cristalli, G.; Muller, C.E. Structure-activity relationships of adenine and deazaadenine derivatives as ligands for adenine receptors, a new purinergic receptor family. J. Med. Chem., 2009, 52(19), 5974-5989.
31. 2 adenosine receptors. J. Med. Chem., 1992, 35(13), 2363-2368.
32. 2B ligands. J. Med. Chem., 2002, 45(15), 3271-3279. (Pubitemid 34774277)
33. 2A receptor. Bioorg. Med. Chem., 2003, 11(10), 2183-2192. (Pubitemid 36457845)
34. Cristalli, G.; Costanzi, S.; Lambertucci, C.; Taffi, S.; Vittori, S.; Volpini, R. Purine and deazapurine nucleosides: synthetic approaches, molecular modelling and biological activity. FARMACO, 2003, 58(3), 193-204. (Pubitemid 36279693)
35. 3 receptor can explain their different biological behavior. J. Mol. Graph. Model., 2003, 21(4), 253-262. (Pubitemid 35441323)
36. 3 receptor. Eur. J. Pharmacol., 2007, 556(1-3), 14-18. (Pubitemid 46073996)
37. Liang, C.W.; Choi, W.J.; Jeong, L.S. Synthesis of 2-alkynyl substituted 4'-thioadenosine derivatives and their binding affinities at the adenosine receptors. Arch. Pharm. Res., 2008, 31(8), 973-977.
38. 3 receptor. J. Med. Chem., 2002, 45(2), 420-429. (Pubitemid 34073459)
39. 3 adenosine receptor. J. Med. Chem., 2007, 50(6), 1222-1230. (Pubitemid 46496322)
40. Kogi, K.; Uchibori, T.; Aihara, K.; Yamaguchi, T.; Abiru, T. Pharmacological profile of the 2-alkynyladenosine derivative 2-octynyladenosine (YT-146) in the cardiovascular system. Jpn J. Pharmacol., 1991, 57(2), 153-165.
41. + channels. Eur J. Pharmacol., 1992, 213(2), 199-204.
42. + channels responsible for adenosine A2 receptor-mediated vasodepression does not involve a pertussis toxin-sensitive G protein. Eur. J. Pharmacol., 1993, 236(2), 255-262. (Pubitemid 23158304)
43. ATP channel involvement in adenosine receptor-mediated dilation of epicardial vessels. Am. J. Physiol., 1994, 267(2 Pt 2), H716-724.
44. 2 receptor-cAMP system in human aortic endothelial cells. Biochem. Biophys. Res. Commun., 1994, 199(2), 905-910.
45. 2 agonist, and adenosine in isolated canine hearts. Tohoku J. Exp. Med., 1999, 188(1), 31-45. (Pubitemid 29357200)
46. 2A receptor agonist, on cAMP production and noradrenaline release in PC12 cells. Jpn J. Pharmacol., 1998, 78(3), 269-277. (Pubitemid 28554193)
47. 2 receptor agonist, in Dahl salt-sensitive rats. Am. J. Hypertens., 1994, 7(11), 984-988. (Pubitemid 24372794)
48. 2 receptor agonist, in the isolated rat femoral artery and vein. Eur. J. Pharmacol., 1995, 281(1), 9-15.
49. 2 stimulation in the nucleus tractus solitarius of spontaneously hypertensive rats. J. Hypertens., 1995, 13(11), 1285-1290. (Pubitemid 26004031)
50. 2 receptor agonist, inhibits neointimal thickening after rat femoral artery endothelium injury. Eur. J. Pharmacol., 1995, 281(2), 205-207.
51. Harada, N.; Okajima, K.; Katsuragi, T. [Adenosine reduces ischemia/reperfusion-induced liver injury by inhibiting leukocyte activation]. Nippon Yakurigaku Zasshi, 1999, 114(Suppl 1), 159P-167P.
52. 2A receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation. J. Pharmacol. Exp. Ther., 2000, 294(3), 1034-1042. (Pubitemid 30666856)
53. Sasamori, J.; Aihara, K.; Yoneyama, F.; Sato, I.; Kogi, K.; Takeo, S. Amelioration of ischemia/reperfusion-induced myocardial infarction by the 2-alkynyladenosine derivative 2-octynyladenosine (YT-146). J. Cardiovasc. Pharmacol, 2006, 47(4), 614-620. (Pubitemid 44309682)
54. Konno, T.; Ohnuma, S.Y.; Uemoto, K.; Uchibori, T.; Nagai, A.; Kogi, K.; Endo, K.; Hosokawa, T.; Nakahata, N. Effects of 2-alkynyladenosine derivatives on intraocular pressure in rabbits. Eur. J. Pharmacol., 2004, 486(3), 307-316. (Pubitemid 38231061)
55. 2A receptor in rabbits. Eur. J. Pharmacol., 2005, 518(2-3), 203-211. (Pubitemid 41133646)
56. 2A receptor in intraocular pressure decrease induced by 2-(1-octyn-1-yl)adenosine or 2-(6-cyano-1-hexyn-1-yl) adenosine. J. Pharmacol. Sci., 2005, 97(4), 501-509. (Pubitemid 40628527)
57. Konno, T.; Uchibori, T.; Nagai, A.; Kogi, K.; Nakahata, N. Effect of 2-(6-cyano-1-hexyn-1-yl)adenosine on ocular blood flow in rabbits. Life Sci., 2007, 80(12), 1115-1122. (Pubitemid 46241216)
58. 2A receptor mediated protective effect of 2-(6-cyano-1-hexyn-1-yl)adenosine on retinal ischaemia/reperfusion damage in rats. Br. J. Ophthalmol., 2006, 90(7), 900-905. (Pubitemid 43974004)
59. 2B receptor for 2-(1-Hexynyl)adenosine. Mol. Pharmacol., 2000, 58(6), 1349-1356.
60. 3 adenosine receptor ligands. Purinergic Signal., 2006, 2(4), 589-594. (Pubitemid 44848670)
61. 3 receptors on CA1 hippocampal neurotransmission during oxygen-glucose deprivation episodes of different duration. Biochem. Pharmacol., 2007, 74(5), 768-779. (Pubitemid 47087760)
62. Bruns, R.F. Adenosine receptor activation in human fibroblasts: nucleoside agonists and antagonists. Can. J. Physiol. Pharmacol., 1980, 58(6), 673-691. (Pubitemid 10090366)
63. 1 receptor. Eur. J. Pharmacol., 1995, 290(3), 189-199.
64. 1 receptor in vivo. J. Pharmacol. Exp. Ther, 1996, 279(3), 1439-1446.
65. 1 receptors. Eur J. Pharmacol., 1997, 334(2-3), 299-307. (Pubitemid 27452001)
66. 3 adenosine receptor. Bioorg. Med. Chem. Lett., 2001, 11(14), 1931-1934. (Pubitemid 32675320)
67. Lambertucci, C.; Costanzi, S.; Vittori, S.; Volpini, R.; Cristalli, G. Synthesis and adenosine receptor affinity and potency of 8-alkynyl derivatives of adenosine. Nucleosides Nucleotides Nucleic Acids, 2001, 20(4-7), 1153-1157. (Pubitemid 32821944)
68. Raberger, G.; Schutz, W.; Kraupp, O. Coronary dilatory action of adenosine analogues: a comparative study. Arch. Int. Pharmacodyn. Ther, 1977, 230(1), 140-149. (Pubitemid 8269469)
69. Cusack, N.J.; Hourani, S.M. 5'-N-ethylcarboxamidoadenosine: a potent inhibitor of human platelet aggregation. Br J. Pharmacol., 1981, 72(3), 443-447. (Pubitemid 11136909)
70. Schutz, W.; Tuisl, E.; Kraupp, O. Adenosine receptor agonists: binding and adenylate cyclase stimulation in rat liver plasma membranes. Naunyn-Schmiedeberg'sArch. Pharmacol., 1982, 319(1), 34-39. (Pubitemid 12093778)
71. 3H]NECA in rat striatal membranes. Mol. Pharmacol., 1986, 29(4), 331-346. (Pubitemid 16078480)
72. Siddiqi, S.M.; Jacobson, K.A.; Esker, J.L.; Olah, M.E.; Ji, X.D.; Melman, N.; Tiwari, K.N.; Secrist, J.A., 3rd; Schneller, S.W.; Cristalli, G.; et al. Search for new purine-and ribose-modified adenosine analogues as selective agonists and antagonists at adenosine receptors. J. Med. Chem., 1995, 38(7), 1174-1188.
73. Cristalli, G.; Vittori, S.; Thompson, R.D.; Padgett, W.L.; Shi, D.; Daly, J.W.; Olsson, R.A. Inhibition of platelet aggregation by adenosine receptor agonists. Naunyn-Schmiedeberg's Arch. Pharmacol., 1994, 349(6), 644-650. (Pubitemid 24205289)
74. 2A adenosine receptor agonist 2-hexynyl-5'-N-ethylcarboxamidoadenosine. Arzneimittelforschung, 1994, 44(12), 1296-1304.
75. 2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas. Brain Res., 1997, 759(1), 41-49. (Pubitemid 27286342)
76. Klotz, K.-N.; Hessling, J.; Hegler, J.; Owman, C.; Kull, B.; Fredholm, B.B.; Lohse, M.J. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn-Schmiedeberg's Arch. Pharmacol., 1998, 357(1), 1-9. (Pubitemid 28085115)
77. Vittori, S.; Camaioni, E.; Costanzi, S.; Volpini, R.; Klotz, K.-N.; Cristalli, G. Synthesis and receptor affinity of polysubstituted adenosines. Nucleosides Nucleotides, 1999, 18(4-5), 739-740. (Pubitemid 29320590)
78. Volpini, R.; Camaioni, E.; Costanzi, S.; Vittori, S.; Klotz, K.-N.; Cristalli, G. Synthesis of di-and tri-substituted adenosine derivatives and their affinities at human adenosine receptor subtypes. Nucleosides Nucleotides, 1999, 18(11-12), 2511-2520. (Pubitemid 30020236)
79. 3 adenosine receptor ligands. Nucleosides Nucleotides Nucleic Acids, 2005, 24(5-7), 935-938. (Pubitemid 41440724)
80. 3 adenosine receptors. J. Med. Chem., 1994, 37(21), 3614-3621. (Pubitemid 24334616)
81. 3 adenosine receptor agonists. J. Med. Chem., 1998, 41(17), 3174-3185. (Pubitemid 28376523)
82. 3 adenosine receptor agonists. Bioorg. Med. Chem. Lett., 2006, 16(9), 2416-2418.
83. 2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation. J. Med. Chem., 1994, 37(11), 1720-1726. (Pubitemid 24195488)
84. Cristalli, G.; Camaioni, E.; Di Francesco, E.; Eleuteri, A.; Vittori, S.; Volpini, R. Potent and selective ligands for adenosine binding sites. Nucleosides Nucleotides, 1997, 16, 1379-1388. (Pubitemid 27494481)
85. 3 receptor-selective agonists. Bioorg. Med. Chem. Lett., 2008, 18(9), 2813-2819. (Pubitemid 351608886)
86. 3 adenosine receptor-selective nucleosides containing a bicyclo[3.1.0]hexane ring system. J. Med. Chem., 2009, 52(23), 7580-7592.
87. 3 adenosine receptor-selective agonists. Bioorg. Med. Chem., 2010, 18(2), 508-517.
88. 14 receptor by a tethered nucleotide. Bioconjug. Chem., 2010, 21(2), 372-384.
89. Nwe, K.; Brechbiel, M.W. Growing applications of "click chemistry" for bioconjugation in contemporary biomedical research. Cancer Biother. Radiopharm., 2009, 24(3), 289-302.
90. Tomalia, D.A.; Reyna, L.A.; Svenson, S. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging. Biochem. Soc. Trans., 2007, 35, 61-67.
91. Kim, Y.; Hechler, B.; Klutz, A.M.; Gachet, C.; Jacobson, K.A. Toward Multivalent Signaling across G Protein-Coupled Receptors from Poly(amidoamine) Dendrimers. Bioconjug. Chem., 2008, 19(2), 406-411. (Pubitemid 351294910)
92. 3 adenosine receptor selectivity of multivalent nucleoside-dendrimer conjugates. J. Nanobiotechnology, 2008, 6, 12.
93. 14 receptor: multivalent effect in G protein-coupled receptor recognition. Bioconjug. Chem., 2009, 20(8), 1650-1659.
94. Camaioni, E.; Di Francesco, E.; Vittori, S.; Volpini, R.; Cristalli, G. Adenosine receptor agonists: synthesis and biological evaluation of the diastereoisomers of 2-(3-hydroxy-3-phenyl-1-propyn-1-yl)NECA. Bioorg. Med. Chem., 1997, 5(12), 2267-2275. (Pubitemid 28012614)
95. 3 adenosine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 1999, 360(2), 103-108. (Pubitemid 29420012)
96. 2B adenosine receptor agonists: synthesis and biological evaluation of 2-phenylhydroxypropynyl adenosine and NECA derivatives. Nucleosides Nucleotides Nucleic Acids, 2004, 23(1-2), 471-481. (Pubitemid 38351991)
97. Ivanov, A.A.; Palyulin, V.A.; Zefirov, N.S. Computer aided comparative analysis of the binding modes of the adenosine receptor agonists for all known subtypes of adenosine receptors. J. Mol. Graph. Model., 2007, 25(5), 740-754. (Pubitemid 46177687)
98. Ivanov, A.A.; Wang, B.; Klutz, A.M.; Chen, V.L.; Gao, Z.G.; Jacobson, K.A. Probing distal regions of the A2B adenosine receptor by quantitative structure-activity relationship modeling of known and novel agonists. J. Med. Chem., 2008, 51(7), 2088-2099. (Pubitemid 351503264)
99. 4. Mol. Pharmacol., 2002, 61(2), 455-462. (Pubitemid 34112821)
100. 2A adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists. Curr. Pharm. Des., 2008, 14(15), 1525-1552. (Pubitemid 351997817)
101. 2A adenosine agonist ATL-146e attenuates acute lethal liver injury in mice. J. Gastroenterol., 2005, 40(5), 526-529. (Pubitemid 40823289)
102. 2A receptor agonist, ATL-146e, prevents concanavalin A-induced acute liver injury in mice. Biochem. Biophys. Res. Commun., 2006, 347(4), 949-954. (Pubitemid 44118210)
103. Chang, C.Z.; Dumont, A.S.; Simsek, S.; Titus, B.J.; Kwan, A.L.; Kassell, N.F.; Solenski, N.J. The adenosine 2A receptor agonist ATL-146e attenuates experimental posthemorrhagic vasospasm. Neurosurgery, 2007, 60(6), 1110-1117; discussion 1117-1118. (Pubitemid 46849862)
104. 2A receptor activation reduces infarct size in the isolated, perfused mouse heart by inhibiting resident cardiac mast cell degranulation. Am. J. Physiol Heart Circ. Physiol, 2008, 295(5), H1825-1833.
105. 2A receptor agonist. Am. J. Physiol. Heart Circ. Physiol., 2009, 297(2), H637-642.
106. Ellman, P.I.; Reece, T.B.; Law, M.G.; Gazoni, L.M.; Singh, R.; Laubach, V.E.; Linden, J.; Tribble, C.G.; Kron, I.L. Adenosine A2A activation attenuates nontransplantation lung reperfusion injury. J. Surg. Res., 2008, 149(1), 3-8.
107. Reece, T.B.; Tribble, C.G.; Okonkwo, D.O.; Davis, J.D.; Maxey, T.S.; Gazoni, L.M.; Linden, J.; Kron, I.L.; Kern, J.A. Early adenosine receptor activation ameliorates spinal cord reperfusion injury. J. Cardiovasc. Med. (Hagerstown), 2008, 9(4), 363-367. (Pubitemid 351374266)
108. 2A adenosine receptor agonists ATL193 and ATL146e administered by either intravenous infusion or bolus injection. Circulation, 2001, 104(10), 1181-1187. (Pubitemid 32830405)
109. Hendel, R.; Stilley, W.B.; Williams, S.P. Unit dosage of Apadenoson. WO/2010/002473, 07.01.2010, 2010.
110. PGxHealth: Drug Development Pipeline (Company website): http://www.pgxhealth.com/development/pipeline.cfm.
111. 2a adenosine receptor agonists. J. Med. Chem., 1995, 38(9), 1462-1472.
112. Cristalli, G.; Camaioni, E.; Costanzi, S.; Vittori, S.; Volpini, R.; Klotz, K.-N. Characterization of potent ligands at human recombinant adenosine receptors. Drug Dev. Res., 1998, 45, 176-181. (Pubitemid 29119602)
113. 3 receptor. J. Med. Chem., 2009, 52(23), 7897-7900.
114. 3 receptor agonists. Bioorg. Med. Chem., 2010, 18(22), 7923-7930.
115. Cristalli, G.; Podda, G.M.; Costanzi, S.; Lambertucci, C.; Lecchi, A.; Vittori, S.; Volpini, R.; Zighetti, M.L.; Cattaneo, M. Effects of 5'-phosphate derivatives of 2-hexynyl adenosine and 2-phenylethynyl adenosine on responses of human platelets mediated by P2Y receptors. J. Med. Chem., 2005, 48(8), 2763-2766. (Pubitemid 40552908)
116. Menegatti, M.; Cristalli, G.; Gallo, L.; Mannucci, P.M.; Pareti, F.I. Effect of adenosine derivatives on in vitro thrombus formation induced by shear stress. Haematologica, 1999, 84(8), 721-725. (Pubitemid 29424408)
117. 2A adenosine receptor agonists. Aucleosides Nucleotides, 1995, 3-5, 449-453.
118. Cristalli, G.; Volpini, R.; Vittori, S.; Camaioni, E. In Adenosine and Adenine Nucleotides: from Molecular Biology to Integrative Physiology. Belardinelli, L.; Pelleg, A., Eds.; Kluwer Academic Publishers: Philadelphia, 1995, pp 140-148.
119. Calleri, E.; Ceruti, S.; Cristalli, G.; Martini, C.; Temporini, C.; Parravicini, C. ; Volpini, R.; Daniele, S.; Caccialanza, G.; Lecca, D.; Lambertucci, C.; Trincavelli, M.L.; Marucci, G.; Wainer, I.W.; Ranghino, G.; Fantucci, P.; Abbracchio, M.P.; Massolini, G. Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor. J. Med. Chem., 2010, 53(9), 3489-3501.
120. Ciana, P.; Fumagalli, M.; Trincavelli, M.L.; Verderio, C.; Rosa, P.; Lecca, D. ; Ferrario, S.; Parravicini, C.; Capra, V.; Gelosa, P.; Guerrini, U.; Belcredito, S.; Cimino, M.; Sironi, L.; Tremoli, E.; Rovati, G.E.; Martini, C.; Abbracchio, M.P. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. EMBO J., 2006, 25(19), 4615-4627. (Pubitemid 44498134)
121. Nakatsuka, T.; Gu, J.G. P2X purinoceptors and sensory transmission. Pflugers Arch., 2006, 452(5), 598-607. (Pubitemid 44015094)
122. 3 receptor ligands. J. Med. Chem., 2009, 52(15), 4596-4603.
123. Ariens, E.J.; Van Rossum, J.M.; Simonis, A.M. Affinity, intrinsic activity and drug interactions. Pharmacol Rev., 1957, 9(2), 218-236.
124. 6-methyl 2'-deoxyadenosine 3', 5'-bisphosphate. Br. J. Pharmacol., 1998, 124(1), 1-3. (Pubitemid 28210035)
125. Baurand, A.; Raboisson, P.; Freund, M.; Leon, C.; Cazenave, J.P.;
126. 1 receptor antagonists. Bioorg. Med. Chem., 2004, 12(7), 1769-1779. (Pubitemid 38340771)
127. 1 receptor ligands. J. Med. Chem., 2000, 43(5), 829-842. (Pubitemid 30152292)
128. 1 receptor antagonist. Br. J. Pharmacol., 2002, 135(8), 2004-2010. (Pubitemid 34478313)
129. 1 receptor antagonists. J. Med. Chem., 2003, 46(23), 4974-4987. (Pubitemid 37352036)
130. 1 receptor with strong antithrombotic activity in mice. J. Pharmacol Exp. Ther, 2006, 316(2), 556-563. (Pubitemid 43130981)
131. Costanzi, S.; Tikhonova, I.G.; Ohno, M.; Roh, E.J.; Joshi, B.V.; Colson, A. O.; Houston, D.; Maddileti, S.; Harden, T.K.; Jacobson, K.A. P2Y1 antagonists: combining receptor-based modeling and QSAR for a quantitative prediction of the biological activity based on consensus scoring. J. Med. Chem., 2007, 50(14), 3229-3241. (Pubitemid 47065972)
132. 1 Receptor Antagonists: 2-Alkynyl (N)-Methanocarba 2'-Deoxyadenosine 3', 5'-Bisphosphate Analogues and Conjugation to a Polyamidoamine (PAMAM) Dendrimer Carrier. Bioconjug. Chem., 2010, 21(7), 1190-1205.
133. Jacobson, K.A. Functionalized Congener Approach to the Design of Ligands for G Protein-Coupled Receptors (GPCRs). Bioconjug. Chem., 2009, 20(10), 1816-1835.
134. 1 receptor with a high affinity radiolabeled antagonist. Mol. Pharmacol., 2002, 62(5), 1249-1257. (Pubitemid 35222517)
135. Harden, T.K.; Hawkins, P.T.; Stephens, L.; Boyer, J.L.; Downes, C.P. Phosphoinositide hydrolysis by guanosine 5'-[gamma-thio]triphosphate-activated phospholipase C of turkey erythrocyte membranes. Biochem. J., 1988, 252(2), 583-593.
136. Boyer, J.L.; Downes, C. P.; Harden, T.K. Kinetics of activation of phospholipase C by P2Y purinergic receptor agonists and guanine nucleotides. J. Biol. Chem., 1989, 264(2), 884-890. (Pubitemid 19038068)